ArticleThe Lancet. Rheumatology2022

Allogeneic mesenchymal stromal cell transplantation for systemic sclerosis.

Elizabeth R Volkmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.